HIV & AIDS

The search for an effective HIV vaccine continues

An HIV vaccine trial that started in 2016 in South Africa was halted in February 2020. The study sponsors made the call after interim results showed that the vaccine, known as HVTN 702, did not prevent HIV. This result was ...

HIV & AIDS

Mathematicians develop a model of the movement of immune cells

Mathematicians from RUDN University have developed a computational model that allows predicting the mobility of T-lymphocytes, immune cells that recognize and destroy viruses. The model will help in the treatment of immune ...

HIV & AIDS

How HIV develops resistance to key drugs discovered

The mechanism behind how HIV can develop resistance to a widely-prescribed group of drugs has been uncovered by new research from the Crick and Dana-Farber Cancer Institute, with the findings opening the door to the development ...

Obstetrics & gynaecology

Neural tube defect prevalence 7.0 per 10,000 in HIV-exposed

(HealthDay)—The prevalence of neural tube defects (NTDs) is 7.0 per 10,000 live births in HIV-exposed pregnancies, which is similar to the prevalence in the general population, according to research published in the Jan. ...

HIV & AIDS

Researchers support new strategies for HIV control

The search for an AIDS cure has partly focused on ways to eradicate infected cells. Now, new research from Karolinska Institutet in Sweden and the University of Pennsylvania in the U.S. shows that this approach may not be ...

Diseases, Conditions, Syndromes

New animal model shows effective treatment for latent tuberculosis

A major goal of tuberculosis (TB) research is to find a way to treat people with the latent (or inactive) form of the disease to keep them from developing symptomatic TB. A breakthrough study using a new animal model developed ...

page 17 from 40